NRX Pharmaceuticals Inc. (NRXP) at a glance

NRX Pharmaceuticals Inc. (NRXP) is a micro-cap Healthcare company. It trades at $3.58, with a P/E of 0.4, a 58.8% profit margin and revenue growth of 8.6%. It does not pay a dividend. Vestovix scores it 60/100 overall. Its strongest dimension is Value (99/100) and its weakest is Safety (32/100). It carries above-market volatility, so expect larger swings.

Price

$3.58

Market cap

$164.4M

P/E ratio

0.4

Dividend yield

None

Beta

2.19

52-week range

$1.62 to $5.06